Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Prepaid Assets (2016 - 2025)

Zevra Therapeutics (ZVRA) has disclosed Prepaid Assets for 10 consecutive years, with $7.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Prepaid Assets rose 225.04% year-over-year to $7.4 million, compared with a TTM value of $7.4 million through Sep 2025, up 225.04%, and an annual FY2024 reading of $4.1 million, up 122.15% over the prior year.
  • Prepaid Assets was $7.4 million for Q3 2025 at Zevra Therapeutics, up from $4.4 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $7.4 million in Q3 2025 and bottomed at $395000.0 in Q1 2021.
  • Average Prepaid Assets over 5 years is $2.5 million, with a median of $2.0 million recorded in 2021.
  • Peak annual rise in Prepaid Assets hit 231.34% in 2021, while the deepest fall reached 55.62% in 2021.
  • Year by year, Prepaid Assets stood at $1.2 million in 2021, then surged by 58.8% to $1.9 million in 2022, then fell by 2.82% to $1.8 million in 2023, then surged by 122.15% to $4.1 million in 2024, then skyrocketed by 82.58% to $7.4 million in 2025.
  • Business Quant data shows Prepaid Assets for ZVRA at $7.4 million in Q3 2025, $4.4 million in Q2 2025, and $3.8 million in Q1 2025.